Growth Metrics

Dare Bioscience (DARE) Other Working Capital Changes (2017 - 2025)

Dare Bioscience's Other Working Capital Changes history spans 10 years, with the latest figure at $470637.0 for Q4 2025.

  • For Q4 2025, Other Working Capital Changes rose 31.03% year-over-year to $470637.0; the TTM value through Dec 2025 reached $65405.0, changed N/A, while the annual FY2025 figure was $65405.0, N/A changed from the prior year.
  • Other Working Capital Changes reached $470637.0 in Q4 2025 per DARE's latest filing, up from -$138894.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $4.2 million in Q4 2022 to a low of -$1.3 million in Q1 2024.
  • Average Other Working Capital Changes over 5 years is $254670.8, with a median of -$39513.0 recorded in 2021.
  • Peak YoY movement for Other Working Capital Changes: soared 10702.53% in 2022, then crashed 1260.71% in 2024.
  • A 5-year view of Other Working Capital Changes shows it stood at -$39513.0 in 2021, then skyrocketed by 10702.53% to $4.2 million in 2022, then plummeted by 117.97% to -$752920.0 in 2023, then surged by 147.7% to $359171.0 in 2024, then skyrocketed by 31.03% to $470637.0 in 2025.
  • Per Business Quant, the three most recent readings for DARE's Other Working Capital Changes are $470637.0 (Q4 2025), -$138894.0 (Q3 2025), and $407172.0 (Q2 2025).